TARS Tarsus Pharmaceuticals, Inc.

Fundamentals / CIK 0001819790 / USD

Tarsus Pharmaceuticals, Inc. reported $682.2M in revenue and a net loss of $702.2M for the trailing twelve months ended September 30, 2026 (up 63.9% year over year), with a -102.0% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open TARS in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

8 fiscal years (2018 to 2025), reported in USD.

$459.2M$229.6M$0-$165.4MFY 2018 Net Income: -$1.32M2018FY 2019 Net Income: -$4.67M2019FY 2020 Revenue: $0FY 2020 Net Income: -$26.81M2020FY 2021 Revenue: $57.03MFY 2021 Net Income: -$13.83M2021FY 2022 Revenue: $25.82MFY 2022 Net Income: -$62.09M2022FY 2023 Revenue: $17.45MFY 2023 Net Income: -$135.9M2023FY 2024 Revenue: $183.0MFY 2024 Net Income: -$115.6M2024FY 2025 Revenue: $451.4MFY 2025 Net Income: -$66.42M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $451.4M $183.0M $17.45M $25.82M $57.03M $0 -- --
Research & Development $64.32M $53.39M $50.31M $42.62M $41.71M $18.83M $3.16M --
Selling, General & Admin $427.3M $237.3M $108.7M $44.95M -- -- -- --
Total Operating Expenses -- -- $160.6M $88.53M $69.18M $27.00M $4.30M --
Operating Income -$70.97M -$120.6M -$143.2M -$62.71M -$12.16M -$27.00M -$4.30M --
EBITDA -$69.15M -$119.3M -$142.3M -$62.39M -$11.86M -$26.90M -$4.26M --
Interest Income $15.75M $15.01M $10.34M $3.50M -- -- -- --
Interest Expense $8.94M $7.85M $3.35M $2.20M $0 -- -- --
Income Before Tax -$64.36M -$115.6M -$135.9M -$62.09M -$13.77M -$26.81M -- --
Income Tax Expense $2.06M $0 $0 -$4.0K $55K $1.0K $1.0K --
Net Income -$66.42M -$115.6M -$135.9M -$62.09M -$13.83M -$26.81M -$4.67M -$1.32M
Basic EPS -$1.59 -$3.07 -$4.62 -$2.52 -$0.67 -$4.32 -$1.98 --
Diluted EPS -$1.59 -$3.07 -$4.62 -$2.52 -$0.67 -$4.32 -$1.98 --
Basic Shares Outstanding 41.8M 37.6M 29.4M 24.6M 20.6M 6.2M 2.4M --
Diluted Shares Outstanding 41.8M 37.6M 29.4M 24.6M 20.6M 6.2M 2.4M --

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $194.6M $173.9M $162.1M $151.7M $118.7M $102.7M $78.33M $66.41M
Cost of Revenue $13.89M $12.11M $9.40M -- $8.31M $6.24M $5.21M --
Gross Profit $180.7M $161.8M $152.7M -- $110.4M $96.42M $73.12M --
Research & Development $44.19M $31.01M $22.35M $18.04M $16.28M $15.59M $14.41M $16.87M
Selling, General & Admin $168.0M $150.7M $136.4M $130.7M $108.6M $103.0M $85.00M $69.03M
Operating Income -$662.1M -$19.91M -$6.12M -$7.98M -$14.53M -$22.18M -$26.28M -$24.42M
EBITDA -$661.1M -$18.91M -$5.68M -$7.53M -$14.13M -$21.78M -$25.82M -$23.99M
Interest Income $3.78M $3.70M $3.72M $3.95M $4.11M $4.23M $3.45M $3.65M
Interest Expense $2.19M $2.16M $2.13M $2.21M $2.27M $2.24M $2.21M $2.31M
Income Tax Expense $4.64M $2.72M $2.35M $2.06M $0 $0 $0 --
Net Income -$668.3M -$18.55M -$6.97M -$8.37M -$12.59M -$20.34M -$25.12M -$23.11M
Basic EPS -$14.40 -$0.43 -$0.16 -- -$0.30 -$0.48 -$0.64 --
Diluted EPS -$14.40 -$0.43 -$0.16 -- -$0.30 -$0.48 -$0.64 --
Basic Shares Outstanding 46.4M 43.4M 43.0M -- 42.6M 42.4M 39.3M --
Diluted Shares Outstanding 46.4M 43.4M 43.0M -- 42.6M 42.4M 39.3M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $183.6M $94.82M $224.9M $71.66M $171.3M $168.1M $57.95M
Short-Term Investments $233.6M $196.6M $2.50M $145.4M $483K $0 --
Cash & Short-Term Investments $417.3M $291.4M $227.4M $217.0M $171.8M $168.1M $57.95M
Accounts Receivable, Net $85.06M $46.76M $16.62M $0 $0 $0 --
Inventory $4.37M $2.62M $3.11M $0 -- -- --
Other Current Assets -- -- -- -- -- -- $0
Total Current Assets $522.8M $356.7M $256.1M $225.4M $176.0M $170.7M $58.03M
Property, Plant & Equipment, Net $11.66M $2.31M $1.47M $957K $755K $548K $154K
Intangible Assets $7.37M $8.33M $3.87M $0 -- -- --
Long-Term Investments $3.87M $3.00M $631K $371K $0 -- --
Other Non-Current Assets $1.86M $999K $1.51M $585K $1.13M $81K $6.0K
Total Non-Current Assets $39.38M $20.29M $9.36M $2.49M $2.96M $1.32M $286K
Total Assets $562.2M $377.0M $265.5M $227.9M $178.9M $172.0M $58.32M
Accounts Payable $16.39M $9.42M $17.77M $5.50M $2.86M $2.24M $456K
Deferred Revenue (Current) -- -- -- $0 $697K $0 --
Other Current Liabilities $16.31M $18.32M -- -- -- -- --
Total Current Liabilities $135.7M $80.61M $36.94M $15.43M $11.48M $5.39M $819K
Long-Term Debt $72.44M $71.84M $29.82M $19.43M $0 -- --
Other Non-Current Liabilities $10.60M $0 $1.75M $100K $699K $605K $100K
Total Non-Current Liabilities $83.04M $71.84M $31.57M $19.53M $699K $605K $100K
Total Liabilities $218.7M $152.5M $68.50M $34.96M $12.18M $5.99M $919K
Total Debt (incl. Leases) $83.04M $72.45M $31.73M $20.32M $1.19M $831K $164K
Common Stock $6.0K $6.0K $5.0K $5.0K $4.0K $4.0K $2.0K
Retained Earnings -$426.6M -$360.2M -$244.7M -$108.8M -$46.67M -$32.84M -$6.03M
Accumulated Other Comp. Income $381K $179K -$2.0K -$74K $0 -- --
Total Stockholders' Equity $343.4M $224.5M $197.0M $192.9M $166.7M $166.0M -$6.00M
Total Equity $343.4M $224.5M $197.0M $192.9M $166.7M $166.0M -$6.00M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $136.5M $204.6M $102.2M $183.6M $112.7M $96.65M $175.8M $94.82M
Short-Term Investments $173.1M $245.1M $286.5M $233.6M $289.1M $284.5M $232.1M $196.6M
Cash & Short-Term Investments $309.6M $449.7M $388.7M $417.3M $401.8M $381.1M $407.9M $291.4M
Accounts Receivable, Net $100.4M $96.03M $100.3M $85.06M $72.62M $58.33M $62.43M $46.76M
Inventory $5.16M $4.38M $4.57M $4.37M $3.84M $3.87M $2.71M $2.62M
Total Current Assets $445.4M $562.0M $537.2M $522.8M $501.7M $474.4M $480.8M $356.7M
Property, Plant & Equipment, Net $20.72M $20.49M $17.67M $11.66M $5.75M $3.18M $2.79M $2.31M
Intangible Assets $16.64M $6.88M $7.13M $7.37M $7.61M $7.85M $8.09M $8.33M
Long-Term Investments $6.68M $6.68M $3.87M $3.87M $3.00M $3.00M $3.00M $3.00M
Other Non-Current Assets $735K $660K $715K $1.86M $1.18M $1.21M $616K $999K
Total Non-Current Assets $60.08M $49.15M $43.91M $39.38M $32.86M $20.57M $19.98M $20.29M
Total Assets $505.5M $611.1M $581.1M $562.2M $534.6M $495.0M $500.8M $377.0M
Accounts Payable $34.69M $40.14M $24.13M $16.39M $40.64M $28.07M $28.38M $9.42M
Other Current Liabilities $32.15M $25.43M $32.50M $16.31M -- -- -- $18.32M
Total Current Liabilities $227.1M $175.8M $143.5M $135.7M $117.0M $90.25M $86.31M $80.61M
Long-Term Debt $72.94M $72.76M $72.60M $72.44M $72.28M $72.13M $71.98M $71.84M
Other Non-Current Liabilities $15.73M $15.89M $16.08M $10.60M $10.15M -- -- $0
Total Non-Current Liabilities $174.4M $88.66M $88.68M $83.04M $82.43M $72.13M $71.98M $71.84M
Total Liabilities $401.5M $264.4M $232.2M $218.7M $199.5M $162.4M $158.3M $152.5M
Total Debt (incl. Leases) $89.43M $88.81M $88.68M $83.04M $82.51M $72.45M $72.37M $72.45M
Common Stock $7.0K $6.0K $6.0K $6.0K $6.0K $6.0K $6.0K $6.0K
Retained Earnings -$1.12B -$452.1M -$433.6M -$426.6M -$418.3M -$405.7M -$385.3M -$360.2M
Accumulated Other Comp. Income -$914K -$557K -$298K $381K $289K $39K $85K $179K
Total Stockholders' Equity $104.0M $346.7M $349.0M $343.4M $335.1M $332.6M $342.5M $224.5M
Total Equity $104.0M $346.7M $349.0M $343.4M $335.1M $332.6M $342.5M $224.5M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$66.42M -$115.6M -$135.9M -$62.09M -$13.83M -$26.81M -$4.67M -$1.32M
Depreciation & Amortization $1.82M $1.23M $877K $326K $300K $100K $37K --
Stock-Based Compensation $41.72M $27.82M $19.83M $13.46M $8.46M $839K $18K --
Change in Receivables -$38.30M -$30.14M -$16.62M $0 -- -- -- --
Change in Inventory -$1.75M -$2.05M -$3.11M $0 -- -- -- --
Operating Cash Flow -$12.45M -$83.03M -$117.5M -$49.03M $3.75M -$21.14M -$3.67M --
Capital Expenditure -$9.86M -$1.57M -$1.50M -$506K -$586K -$456K -$175K --
Free Cash Flow -$22.31M -$84.59M -$119.0M -$49.54M $3.16M -$21.59M -$3.85M --
Purchases of Investments -$393.2M -$262.6M -$28.66M -$149.4M $0 -- -- --
Investing Cash Flow -$42.12M -$199.2M $140.6M -$144.6M -$586K -$456K -$175K --
Financing Cash Flow $143.4M $154.7M $130.2M $93.99M $21K $131.8M $59.45M --
Net Change in Cash $88.82M -$127.6M $153.3M -$99.67M $3.18M $110.2M $55.60M --

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$668.3M -$18.55M -$6.97M -$8.37M -$12.59M -$20.34M -$25.12M -$23.11M
Depreciation & Amortization $1.00M $1.00M $437K $443K $400K $400K $460K $432K
Stock-Based Compensation $27.22M $13.29M $11.97M $14.31M $12.24M $8.23M $6.93M $7.40M
Change in Receivables -$4.41M $19.32M -$30.29M -$12.44M -$14.29M $4.09M -$15.67M -$17.60M
Change in Inventory -$781K $198K -$196K -$536K $37K -$1.17M -$84K $227K
Operating Cash Flow -$6.00M $61.22M -$24.65M $19.33M $18.26M -$29.39M -$20.65M -$22.18M
Capital Expenditure -$1.21M -$4.07M -$5.82M -$6.36M -$1.91M -$1.00M -$590K -$72K
Free Cash Flow -$7.21M $57.15M -$30.47M $12.97M $16.35M -$30.39M -$21.24M -$22.25M
Purchases of Investments $0 -$2.40M -$126.8M -$35.58M -$102.3M -$129.7M -$125.6M -$89.97M
Investing Cash Flow -$189.5M $37.88M -$58.56M $49.27M -$4.74M -$51.70M -$34.94M -$59.57M
Common Stock Issued $113.1M $0 $0 -- $0 -$354K $135.1M --
Financing Cash Flow $127.8M $3.30M $1.20M $2.31M $2.56M $1.95M $136.6M $2.93M
Net Change in Cash -$67.68M $102.4M -$82.01M $70.92M $16.08M -$79.14M $80.97M -$78.83M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -15.7% -65.9% -820.5% -242.9% -21.3% -- -- --
Net Profit Margin -14.7% -63.2% -778.9% -240.5% -24.2% -- -- --
Return on Equity (ROE) -19.3% -51.5% -69.0% -32.2% -8.3% -16.2% -- --
Return on Assets (ROA) -11.8% -30.7% -51.2% -27.2% -7.7% -15.6% -8.0% --
Current Ratio 3.85x 4.42x 6.93x 14.61x 15.33x 31.68x 70.85x --
Quick Ratio 3.82x 4.39x 6.85x 14.61x 14.97x 31.21x 70.76x --
Debt to Equity 0.24x 0.32x 0.16x 0.11x 0.01x 0.01x -- --
Revenue Growth (YoY) +146.7% +948.6% -32.4% -54.7% -- -- -- --
Operating Cash Flow Growth (YoY) -- -- -- -1408.2% -- -- -- --
Free Cash Flow Growth (YoY) -- -- -- -1666.6% -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -102.0% -8.0% -9.5% -15.7% -23.9% -33.2% -46.7% -65.9%
Net Profit Margin -102.9% -7.7% -9.0% -14.7% -22.2% -31.1% -44.9% -63.2%
Return on Equity (ROE) -675.0% -13.4% -13.8% -19.3% -24.2% -27.7% -30.6% -51.5%
Return on Assets (ROA) -138.9% -7.6% -8.3% -11.8% -15.2% -18.6% -21.0% -30.7%
Current Ratio 1.96x 3.20x 3.74x 3.85x 4.29x 5.26x 5.57x 4.42x
Quick Ratio 1.94x 3.17x 3.71x 3.82x 4.25x 5.21x 5.54x 4.39x
Debt to Equity 0.86x 0.26x 0.25x 0.24x 0.25x 0.22x 0.21x 0.32x
Revenue Growth (YoY) +63.9% +69.4% +106.9% +128.4% +146.7% +151.5% +183.7% +407.9%
Gross Profit Growth (YoY) +63.7% +67.8% +108.8% -- -- -- -- --
Operating Cash Flow Growth (YoY) -132.9% -- -- -- -- -- -- --
Free Cash Flow Growth (YoY) -144.1% -- -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001819790) · from December 31, 2018 Data through September 30, 2026 · synced Nov 20, 2026, 05:18 UTC · Open in terminal